Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate therapy improved hair loss and reduced testosterone levels in a menopausal woman.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Medroxyprogesterone acetate improved sleep apnea symptoms in some obese patients.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

Combined oral contraceptives and antiandrogens are effective for treating PCOS symptoms in older women.

Low-potency steroids can cause serious side effects in people with skin conditions like Netherton syndrome.

Most patients with PCOS were prescribed medroxyprogesterone acetate or oral contraceptives, with some experiencing side effects or needing prescription changes.

Co-trimoxazole successfully treated a girl with multiple autoimmune symptoms.

Bicalutamide mesotherapy improved hair density in women with hair loss and was well received.

Topical cyclosporin may help delay hair loss.

The treatment was effective for advanced non-Hodgkin's lymphomas.

Methotrexate is effective for rheumatoid arthritis but can cause side effects.

Cyproterone acetate effectively treats hirsutism and related conditions.

Cyproterone acetate can effectively treat idiopathic hirsutism, but ethinyl oestradiol and lynoestrenol may not always reduce hair growth.

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

Topical glucocorticoids thin the skin and change collagen structure.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.

Intravenous cyclophosphamide effectively treated steroid-resistant lupus cystitis and peritonitis.

Cyclosporine A treatment caused rare hair repigmentation in a 65-year-old man.

A woman developed Cushing syndrome and adrenal insufficiency from using fluticasone and ritonavir together.

Nandrolone might increase muscle mass with fewer side effects than testosterone but could cause erectile dysfunction and needs more research.

Cyclosporin A does not change sex hormone levels.

Different medications improved various PCOS symptoms and quality of life in Pakistani women, but did not significantly help with excessive hair growth.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Diane and Androcur 10 improved acne and seborrhea in most women, and hirsutism and alopecia in about half.